Detect Eight Cancers Early with a Single Blood Draw.

Serenity™ guides your doctor in the early detection of 8 cancers at early stages when they can still be stopped.


Detect and Manage Mutations

If you or someone in your family has tested positive for a high-risk cancer gene like BRCA, CHEK-2, ATM, BARD1, CDH1, you may know that you are at an increased risk of developing certain cancers.
 
However, a positive test result cannot determine if you will actually develop cancer. 

That’s why a routine and effective way of detecting cancer mutations early is especially critical for people with hereditary high-risk cancer genes. 

Serenity is the first test that helps guide physicians in the early detection of 8 cancers (lung, breast, prostate, colon, pancreatic, liver, bladder, stomach) at early stages in the blood. It can help detect a single molecule of cancer DNA in your blood. 

So, you can use Serenity on a routine basis to proactively detect active cancer mutations.

Stay Informed

High-Risk
Gene

Cancer
Risks

Serenity
Appropriate

CHEK-2

ATM

BARD1

CDH1

NBN

NF1

PALB2

PTEN

RAD51D

STK11

TP53

BRCA2

Breast, Ovarian

Breast, Pancreatic, Prostate

Breast, Ovarian

Stomach, GI

Breast, Ovarian, Prostate

Breast

Breast, Ovarian, Prostate

Breast, Endometrial, Prostate, Lung

Breast, Ovarian, Lung

Breast, Bone, Leukemia, Sarcomas

Breast, Ovarian, Prostate

Breast, Ovarian

Serenity is the first test that helps guide physicians in the early detection of 8 cancers, including breast at early stages in the blood. Serenity can help detect a single molecule of cancer DNA in your blood. So, you can take Serenity on a routine basis to proactively monitor cancer mutations. 

The Future of Early Cancer Detection is Coming

Finally, take your health into your own hands. Be the first to know when Serenity is available. 

Clinical Validation

Serenity has been studied in one of the largest cfDNA clinical trials across 15 cancer types and 13 leading oncology centers in the US, Germany, and Switzerland.

Delivered by Experts

Expert physician support is at the core of Serenity. From answering questions to interpreting your results, Serenity is by your side.

Innovative Early Detection Technology

Serenity combines precision sequencing with artificial intelligence to detect very small traces of cancer-related mutations in the blood. This is a new way to screen for cancer using cell-free DNA (cfDNA) from a simple blood draw.

Serenity will be available in 2020. Sign up now to be first in line to take control of your health with the world’s first blood test for early cancer detection.

Stay Informed